Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, U.K. and Cambridge, USA : Blackwell Science Ltd
    Scandinavian journal of immunology 43 (1996), S. 0 
    ISSN: 1365-3083
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Moderate exercise appears to stimulate the immune system, but there is good evidence that intense exercise can cause immune deficiency. In the present study the authors examined the effect of continuous physical exercise (35% of VO2 max), calorie deficiency and sleep deprivation on the immune system of young men participating in a 5–7 days military training course. There was a two–three fold increase of neutrophils from day 1, the values remained high and decreased slightly at the end of the course. Monocyte counts also increased with a pattern similar to that of neutrophils. Eosinophils decreased to 30% of control and lymphocyte numbers decreased by 30–40%. All the major subgroups (CD4 T cells , CD8 T cells, B cells, NK cells) were reduced. Neutrophil function, as tested by measuring chemotaxis, was significantly stimulated during the first days of the course, in particular in the group with the lowest calorie intake. The mitogenic response of lymphocytes to PHA and Con A was variable, ranging from stimulation during one course to no effect in another course. Serum levels of immunoglobulins decreased significantly during the course. IgG was reduced by 6–7%, IgA by 10–20% and IgM by 20–35%. The authors found no changes of interleukin 1, 2 and 4 during the course, but a (12–20%) reduction (P〈0.01) of interleukin 6 , and an increase (P〈0.01) of granulocyte–macrophage colony stimulating factor. Altogether the results from the ranger course present a mixed-up picture. The non-specific phagocyte-related immunity was enhanced. On the other hand, the data indicate that even a moderate physical activity, around the clock, caused significant suppression of a number of parameters reflecting the status of the specific, lymphocyte-related immunity. It is noteworthy, however, that there was no significantly increased infection rate during the course or in the first 4–5 weeks thereafter.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Clinica Chimica Acta 15 (1967), S. 361-362 
    ISSN: 0009-8981
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1439-0973
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Bei 56 Patienten mit klinisch und durch Laborparameter gesicherter infektiöser Mononukleose und Krankheitsdauer von nicht mehr als sieben Tagen wurde im Rahmen einer Doppelblindstudie entweder eine orale Therapie mit 800 mg Aciclovir fünfmal täglich oder mit Placebo über sieben Tage durchgeführt. Bei allen Patienten wurden sechs Monate lang klinische, virologische und immunologische Parameter überwacht. Unter der Therapie war bei 36 überprüften Patienten die Ausscheidung von Epstein-Barr-Virus signifikant vermindert (p〈0,001). Eine Woche nach Therapieende war die Virusproduktion im Oropharynx jedoch wieder so ausgeprägt wie vor der Therapie. Bei Aufnahme in die Studie wurde bei 35 der 36 Patienten der Therapiegruppe Epstein-Barr-Virus nachgewiesen, sechs Monate nach Therapieende bei 28 Patienten. Ein Einfluß der Therapie auf den klinischen Verlauf der Erkrankung konnte nicht festgestellt werden. Die spezifische Antikörperantwort auf das Virus war ebenfalls unbeeinflußt. 180 Tage nach Therapieende fand sich bei vier der mit Aciclovir behandelten und bei sechs der Patienten der Kontrollgruppe eine signifikante Verminderung des spontanen Wachstums von mit Epstein-Barr-Virus infizierten Lymphozytenin vivo (p〈0,001). Bei drei weiteren Patienten mit schwersten klinischen Symptomen mit Atemwegsverlegung und/oder disseminierter intravasaler Koagulopathie wurde eine kombinierte Therapie mit dreimal täglich 10 mg Aciclovir/kg i. v. und 0,7 mg Prednisolon/kg täglich über zehn Tage durchgeführt. Die Virusausscheidung sistierte vorübergehend unter der Behandlung, kehrte jedoch innerhalb einer Woche nach Therapie wieder zu den Anfangswerten zurück. Die Kombinationstherapie führte bei zwei der Patienten mit Atemwegsobstruktion zu einer dramatischen Besserung des Pharynxödems und des Allgemeinzustandes, bei dem Patienten mit intravasaler Koagulopathie war die Wirkung sehr viel weniger ausgeprägt.
    Notes: Summary Fifty-six patients with a clinical and laboratory diagnosis of infectious mononucleosis who had not been ill for more than seven days, were randomised for peroral treatment with acyclovir (800 mg five times daily) or placebo for seven days in a double blind trial. Clinical, virological and immunological parameters were monitored in each patient for six months. During treatment, shedding of Epstein-Barr virus' as assessed in 36 patients, was significantly reduced (p〈0.001). However, virus production in the oropharynx returned to pre-treatment levels one week after the cessation of therapy. Virus was detected in 35 patients at enrollment and in 28 of 36 patients at the six-month control. No effect on the clinical course of the disease was noticed. The virus-specific antibody response was also unaffected. A significant reduction in spontaneous outgrowth ofin vivo Epstein-Barr virus-infected B-lymphocytes was found at 180 days after treatment in four acyclovir-treated patients compared to six controls (p〈0.001). In another three patients with over-whelming clinical symptoms causing airway obstruction and/or disseminated intravascular coagulopathy, treatment with intravenous acyclovir (10 mg/kg three times daily) was combined with prednisolone (0.7 mg/kg daily) for ten days. Virus shedding ceased transiently during treatment, but returned to initial levels within one week. A dramatic clinical effect on the pharyngeal oedema and general health of the two patients with airway obstruction was noticed, but was much less evident in a patient with intravascular coagulopathy.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...